News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,856 Results
Type
Article (40741)
Company Profile (263)
Press Release (661852)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205190)
Career Advice (2015)
Deals (35530)
Drug Delivery (95)
Drug Development (81182)
Employer Resources (172)
FDA (16194)
Job Trends (14898)
News (346486)
Policy (32632)
Tag
Academia (2603)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49917)
ALS (90)
Alzheimer's disease (1381)
Antibody-drug conjugate (ADC) (124)
Approvals (16200)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11669)
BIOSECURE Act (20)
Biosimilars (105)
Biotechnology (189)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (279)
Cancer (2267)
Cardiovascular disease (174)
Career advice (1684)
Career pathing (30)
CAR-T (152)
Cell therapy (424)
Cervical cancer (19)
Clinical research (66059)
Collaboration (840)
Company closure (1)
Compensation (535)
Complete response letters (19)
COVID-19 (2603)
CRISPR (41)
C-suite (243)
Cystic fibrosis (100)
Data (2207)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (270)
Diagnostics (6447)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86751)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (112923)
Executive appointments (724)
FDA (17460)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (748)
Gene editing (108)
Generative AI (20)
Gene therapy (304)
GLP-1 (710)
Government (4435)
Grass and pollen (4)
Guidances (67)
Healthcare (18892)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2745)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (311)
IPO (16551)
IRA (40)
Job creations (3645)
Job search strategy (1430)
Kidney cancer (10)
Labor market (38)
Layoffs (469)
Leadership (17)
Legal (7924)
Liver cancer (76)
Lung cancer (324)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13439)
Medtech (13444)
Mergers & acquisitions (19522)
Metabolic disorders (686)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1920)
NextGen: Class of 2025 (6547)
Non-profit (4501)
Now hiring (39)
Obesity (365)
Opinion (209)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57631)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20601)
Phase II (29087)
Phase III (21670)
Pipeline (1205)
Policy (139)
Postmarket research (2563)
Preclinical (8773)
Press Release (65)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (381)
Real estate (5942)
Recruiting (65)
Regulatory (22347)
Reports (46)
Research institute (2369)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (131)
Series B (84)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3613)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (690)
Venture capitalists (42)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (143)
Last 7 days (905)
Last 30 days (2612)
Last 365 days (32904)
2025 (10750)
2024 (35373)
2023 (40238)
2022 (51350)
2021 (55891)
2020 (54263)
2019 (46724)
2018 (35177)
2017 (32325)
2016 (31740)
2015 (37796)
2014 (31506)
2013 (26578)
2012 (28772)
2011 (29413)
2010 (27526)
Location
Africa (728)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38264)
Australia (6231)
California (6158)
Canada (2017)
China (524)
Colorado (266)
Connecticut (280)
Delaware (148)
Europe (82004)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (537)
India (25)
Indiana (307)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4602)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1727)
New Mexico (28)
New York (1752)
North Carolina (972)
North Dakota (9)
Northern California (2687)
Ohio (205)
Oklahoma (14)
Oregon (34)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (33)
South America (1101)
South Carolina (23)
South Dakota (1)
Southern California (2312)
Tennessee (102)
Texas (908)
United States (23215)
Utah (181)
Virginia (145)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (55)
702,856 Results for "radiant genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting
April 25, 2025
·
1 min read
Press Releases
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
March 20, 2025
·
6 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Radiant to Assess Multi-Valent, Multi-Specific Multabodies as Potential Treatments for HIV
Radiant Biotherapeutics, a startup biotechnology company developing a revolutionary antibody platform to deliver transformative therapies for patients facing life-changing disease, announced it has received a USD $2 million grant from the Bill & Melinda Gates Foundation to develop the next generation of HIV biologics based on Radiant’s Multabody™ platform.
December 20, 2023
·
3 min read
Press Releases
Moss Genomics Launches “Perennial” Genomics Platform, Closes on 130 ETH
April 28, 2025
·
7 min read
Press Releases
Radiant Bio Closes $35 Million Series A Financing to Advance Therapeutic Pipeline with Its Proprietary Multabody™ Platform
September 11, 2024
·
4 min read
BioMidwest
SkinMedica® Celebrates 25 Years of Empowering Radiant Skin
Allergan Aesthetics, an AbbVie company, the makers of BOTOX® Cosmetic, is celebrating 25 years of SkinMedica®.
June 6, 2024
·
8 min read
Press Releases
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
February 25, 2025
·
7 min read
Press Releases
BioSkryb Genomics and Ultima Genomics Launch Collaborative Grant Program to Advance Oncology Research
April 23, 2025
·
5 min read
Press Releases
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
January 14, 2025
·
5 min read
1 of 70,286
Next
